Cargando…

The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations

The aim of this study was to compare various formulations solid dispersion pellets (SDP), nanostructured lipid carriers (NLCs) and a self-microemulsifying drug delivery system (SMEDDS) generally accepted to be the most efficient drug delivery systems for BCS II drugs using fenofibrate (FNB) as a mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Tengfei, Qi, Jianping, Lu, Yi, Wang, Kai, Tian, Zhiqiang, Hu, Kaili, Yin, Zongning, Wu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180958/ https://www.ncbi.nlm.nih.gov/pubmed/25248304 http://dx.doi.org/10.1186/s12951-014-0039-3

Ejemplares similares

Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems
por: Wang, Kai, et al.
Publicado: (2014)

Fenofibrate modified-release pellets with lag phase and high oral bioavailability
por: Li, Fang, et al.
Publicado: (2018)

Manufacturing Different Types of Solid Dispersions of BCS Class IV Polyphenol (Daidzein) by Spray Drying: Formulation and Bioavailability
por: Panizzon, Gean Pier, et al.
Publicado: (2019)

Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Preparation and Evaluation of Lipid-Based Liquid Crystalline Formulation of Fenofibrate
por: Kazemi, Moloud, et al.
Publicado: (2018)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
por: Lin, You-Meei, et al.
Publicado: (2011)

In Vitro and In Vivo Evaluation of Oral Controlled Release Formulation of BCS Class I Drug Using Polymer Matrix System
por: Arafat, Mosab, et al.
Publicado: (2021)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability
por: Khames, Ahmed
Publicado: (2019)

Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax
por: Koehl, Niklas J., et al.
Publicado: (2020)

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug
por: Mohsin, Kazi, et al.
Publicado: (2016)

Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation
por: Angiolillo, Dominick J., et al.
Publicado: (2020)

A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology
por: Liu, Hongfei, et al.
Publicado: (2018)

Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation
por: Yousaf, Abid Mehmood, et al.
Publicado: (2015)

Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate
por: Yousaf, Abid Mehmood, et al.
Publicado: (2016)

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders
por: Górniak, Agata, et al.
Publicado: (2023)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

A High Bioavailability and Sustained-Release Nano-Delivery System for Nintedanib Based on Electrospray Technology [Corrigendum]
Publicado: (2021)

Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin
por: Song, Jae Geun, et al.
Publicado: (2022)

Aminoclay–lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption
por: Yang, Liang, et al.
Publicado: (2016)

Nose to Brain Delivery of Phenytoin Sodium Loaded Nano Lipid Carriers: Formulation, Drug Release, Permeation and In Vivo Pharmacokinetic Studies
por: Nair, Sreeja C., et al.
Publicado: (2021)

Bioavailability of a Lipidic Formulation of Curcumin in Healthy Human Volunteers
por: Pawar, Yogesh B., et al.
Publicado: (2012)

Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
por: Sahin, Kazim, et al.
Publicado: (2021)

BCS glossary of computing
por: Burdett, Arnold, et al.
Publicado: (2016)

BCS: 50 years
por: Cooper, Leon N, et al.
Publicado: (2011)

Slow drug delivery decreased total body clearance and altered bioavailability of immediate‐ and controlled‐release oxycodone formulations
por: Li, Yan, et al.
Publicado: (2016)

Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
por: Kaneko, Kenichi, et al.
Publicado: (2022)

Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate
por: Bai, Andi, et al.
Publicado: (2018)

The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation
por: Braeckmans, Marlies, et al.
Publicado: (2022)

Supersaturation and Solubilization upon In Vitro Digestion of Fenofibrate Type I Lipid Formulations: Effect of Droplet Size, Surfactant Concentration and Lipid Type
por: Katev, Vladimir, et al.
Publicado: (2021)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
por: M. Tawfeek, Hesham, et al.
Publicado: (2020)

Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
por: Sahin, Kazim, et al.
Publicado: (2021)

Formulation and Solid State Characterization of Nicotinamide-based Co-crystals of Fenofibrate
por: Shewale, Sheetal, et al.
Publicado: (2015)

Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)

Logic of Selecting Suitable Dissolution Parameters in New Drug Formulations Based on A BCS Approach
por: Medina-López, Raúl, et al.
Publicado: (2020)

Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir
por: Hassan, Haniza, et al.
Publicado: (2021)

BCS Glossary of Computing and ICT
por: Panel, BCS Education and Training Expert, et al.
Publicado: (2008)

Can BCS and BEC be synthetized?
por: Aguilera-Navarro, V C, et al.
Publicado: (1997)

BCS glossary of computing and ICT
por: BCS Learning and Development
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6irh8er4vn6gk39b56l7aiafeb